STOCKS TELEGRAPH

Tag: ONTX

  • Pre-Market Cues: 29 Stocks Roaring for Change On December 24th

    Pre-Market Cues: 29 Stocks Roaring for Change On December 24th

    ‎Ocugen Inc. (OCGN) stock plunged -8.85% to $2.37 in the pre-market trading after ‎reporting the appointment of a vaccine scientific advisory board comprised of leading academic and ‎industry experts in the vaccine field.‎

    ‎Sundial Growers Inc. (SNDL), a Drug Manufacturers – Specialty & Generic ‎company, ‎dropped about -3.24% at $0.4838 in pre-market trading Thursday.‎

    ‎Jaguar Health Inc. (NASDAQ: JAGX) shares are trading down -22.43% at $0.83 at the ‎time of writing after signing second agreement for $6 million non-dilutive financing transaction ‎involving the sale of royalty rights related to future Mytesi (Crofelemer) and Lechlemer revenue ‎Sstream. Company’s 52-week ranged between $0.19 to $1.08. Analysts have a consensus price target ‎of $2. ‎

    ‎Onconova Therapeutics Inc. (ONTX) stock moved down -7.92 percent to ‎‎$0.465 ‎in ‎the pre-market trading.‎

    ‎Acasti Pharma Inc. (ACST) tumbled over -4.77% at $0.4095 in pre-market trading ‎today following the announcement from the company that the Company’s management and Board of ‎Directors are unaware of any material change in the Company’s operations that would account for the ‎recent increase in market activity.‎

    ‎FuelCell Energy Inc. (FCEL) lost over -4.55% at $12.81 in pre-‎market ‎trading ‎Thursday ‎December 24, 2020.‎

    ‎Bionano Genomics Inc. (NASDAQ: BNGO) shares are trading down -3.87% at $0.745 ‎at the time of writing after the company announced publication revealing in side-by-side comparison ‎that method using PacBio sequencing ‎detects only 72% of the large structural variants detected by ‎optical Genome Mapping with Saphyr.‎ Company’s 52-week ranged between $0.25 to $1.39. Analysts ‎have a consensus price target of $1.25. ‎

    ‎Marathon Patent Group Inc. (NASDAQ: MARA) shares are trading ‎up ‎‎7.31% ‎at ‎‎$11.6 ‎at the time of writing. Company’s 52-week ranged between $0.35 to ‎‎$14.08. ‎Analysts ‎have ‎a ‎consensus price target of $7.50.‎

    ‎Zomedica Corp. (ZOM) is down more than -2.48% at $0.22 in pre-‎‎‎market ‎hours ‎Thursday December 24, 2020. The stock had jumped over 17.50% to $0.23 in ‎the ‎last ‎trading ‎session.‎

    ‎Nano Dimension Ltd. (NNDM) is up more than 7.18% at $9.4 in pre-‎‎market ‎hours ‎Thursday December 24, 2020. The stock had dropped over -3.41% to $8.77 in the ‎last ‎trading ‎session.‎

    Before the trading started on December 24, 2020, Senseonics Holdings Inc. (SENS) is ‎up 79.29% to reach $1.16 following its declaration of financial and operational business updates. It has ‎been trading in a 52-week range of $0.35 to $1.78.‎

    ‎Corbus Pharmaceuticals Holdings Inc. (CRBP) lost over -2.08% at $1.41 in pre-‎‎market ‎trading Thursday December 24, 2020.‎

    Before the trading started on December 24, 2020, Foresight Autonomous ‎Holdings ‎Ltd. ‎‎(FRSX) is down -20.87% to reach $4.55. It has been trading in a 52-week range ‎of $0.46 ‎to ‎‎$3.40.‎

    ‎Canaan Inc. (CAN) is up more than 2.12% at $3.85 in pre-‎market ‎hours ‎Thursday ‎December 24, 2020. The stock had dropped over -8.94% to $3.77 in the last ‎trading ‎session.‎

    ‎Avinger Inc. (AVGR) stock soared 76.25% to $0.61 in the pre-market trading after ‎reporting results of its annual meeting of stockholders. The most recent rating by Ladenburg ‎Thalmann, on March 09, 2018, is a Buy.‎

    ‎Triterras Inc. (NASDAQ: TRIT) shares are trading up 16.58% at $14.06 ‎at ‎the ‎time ‎of ‎writing. Company’s 52-week ranged between $7.70 to $15.17. Analysts have ‎a ‎consensus ‎price ‎target ‎of $23.‎

    ‎Tantech Holdings Ltd (TANH), a Household & Personal Products ‎company, ‎rose ‎about 3.29% at $1.57 in pre-market trading Thursday.‎

    ‎Tonix Pharmaceuticals Holding Corp. (TNXP) grew over 36.36% at $0.9 in pre-market ‎trading today following the announcement from the firm that it has completed the purchase of an ‎approximately 44-acre site in Hamilton, Montana, for the construction of a vaccine development and ‎commercial scale manufacturing facility. ‎

    ‎Gold Resource Corporation (GORO) stock moved down -6.85 percent to ‎‎$3.4 ‎in ‎the ‎pre-market trading.‎

    ‎Nikola Corporation (NKLA) gained over 1.8% at $15.3 in pre-market trading ‎Thursday December 24, 2020. The company reported, on Wednesday, that Nikola and Republic ‎Services (RSG) have discontinued their collaboration on refuse truck development.‎

    ‎Molecular Data Inc. (MKD) gained over 2.94% at $0.9027 in pre-‎‎‎market ‎trading ‎Thursday December 24, 2020.‎

    ‎Gevo Inc. (GEVO), a Specialty Chemicals company, rose about 1.03% at $2.94 in pre-‎‎‎‎‎‎market trading Thursday.‎

    ‎IZEA Worldwide Inc. (NASDAQ: IZEA) shares are trading up 3.9% at $1.6 at the time ‎of writing after reporting that it has set a Managed Services bookings record for the best Q4 in ‎company history. Company’s 52-week ranged between $0.07 to $3.13. IZEA Managed Services ‎Bookings Top 40% Growth in Q4 to Hit Record.‎

    ‎Novan Inc. (NOVN) grew over 6.81% at $0.737 in pre-market trading today.‎

    Before the trading started on December 24, 2020, ReWalk Robotics Ltd. (RWLK) is ‎up 9.2% to reach $1.9. The firm recently revealed that it has donated one of its ReStore Exo-suits to ‎Brooks Rehabilitation, located in Jacksonville, Florida. It has been trading in a 52-week range of $0.41 to ‎‎$2.71.‎

    ‎Inuvo Inc. (AMEX: INUV) shares are trading up 2.16% at $0.52 at the ‎time ‎of ‎writing. ‎Company’s 52-week ranged between $0.09 to $1.11. Analysts have a consensus price ‎target ‎of ‎‎$2.25.‎

    ‎Aurora Mobile Limited (JG) stock soared 8.16% to $4.11 in the pre-market trading ‎following the announcement of a partnership deal with Taikang Life Insurance Co., Ltd., to strengthen ‎smart insurance solutions with AI rechnologies. The most recent rating by Goldman, on March 06, ‎‎2019, is a Neutral.‎

    ‎fuboTV Inc. (FUBO) stock soared 3.73% to $54.55 in the pre-market ‎trading. ‎The ‎most recent rating by BMO Capital Markets, on December 23, 2020, is a Market perform.‎

    ‎Farmmi Inc. (FAMI) is down more than -2.61% at $1.12 in pre-market hours ‎Thursday December 24, 2020. The company recently revealed its sales win to multi-channel ‎customers with over 100 retail stores in China and Canada. The stock had jumped over 1.77% to $1.15 ‎in the last trading session.‎

  • 24 stocks trending in pre-market

    ‎Ocugen Inc. (OCGN) stock soared 77.6% to $1.43 in the pre-market trading after ‎signing a binding letter of intent (LOI) with Bharat Biotech to develop Bharat Biotech’s COVID-19 ‎vaccine candidate, COVAXIN, for the United States market.‎

    ‎Sundial Growers Inc. (NASDAQ: SNDL) shares are trading up 1.25% at $0.486 at the ‎time of writing after announcing completion of financial restructuring and debt-free status. Company’s ‎‎52-week ranged between $0.14 to $3.88. COVID-19 Pandemic – The government presents its daily ‎update.‎

    ‎Jaguar Health Inc. (JAGX), a Biotechnology company, rose about 55.89% at $0.617 in ‎pre-market trading Wednesday after releasing voting results from special meeting of stockholders & ‎December 23rd investor webinar.‎

    ‎FuelCell Energy Inc. (FCEL) stock moved up 8.42 percent to $11.65 in the pre-market ‎trading.‎

    ‎Onconova Therapeutics Inc. (ONTX) gained over 32.93% at $0.57 in pre-market ‎trading Wednesday December 23, 2020 following the announcement of FDA permission for study to ‎proceed under its investigational new drug application for multi-kinase CDK4/6 Inhibitor ON 123300.‎

    ‎Castor Maritime Inc. (CTRM) is up more than 2.39% at $0.1585 in pre-‎market ‎hours ‎Wednesday December 23, 2020. The stock had dropped over -2.33% to $0.15 in the ‎last ‎trading ‎session.‎

    ‎Riot Blockchain Inc. (RIOT) is down more than -4.4% at $14.0 in pre-market hours ‎Wednesday December 23, 2020 after reporting an expected 65% increase in bitcoin mining hash rate ‎capacity resulting from the purchase and future deployment of 15,000 S19 Pro and S19j Pro Antminers ‎from Bitmain Technologies Limited .The stock had jumped over 32.65% to $14.65 in the last trading ‎session.‎

    Before the trading started on December 23, 2020, Ideanomics Inc. (IDEX) is up ‎‎4.21% to reach $2.23. It has been trading in a 52-week range of $0.28 to $4.75.‎

    ‎Aurora Mobile Limited (JG) tumbled over -1.46% at $4.72 in pre-market trading ‎today after reporting that it has entered into a partnership agreement a global leading new energy ‎vehicle manufacturer to deliver an enhanced intelligent driving experience.‎

    ‎Velodyne Lidar Inc. (VLDR) is up more than 6.21% at $29.08 in pre-market hours ‎Wednesday December 23, 2020 after revealed the joining of the Qualcomm smart cities accelerator ‎program. The stock had jumped over 10.94% to $27.38 in the last trading session.‎

    ‎Magnite Inc. (NASDAQ: MGNI) shares are trading up 17.21% at $31.81 ‎at ‎the ‎time ‎of ‎writing. Company’s 52-week ranged between $4.09 to $26.63. Analysts have ‎a ‎consensus ‎price ‎target ‎of $30.‎

    ‎Sorrento Therapeutics Inc. (SRNE) grew over 10.66% at $7.99 in pre-market trading ‎today after declaring that it has submitted an emergency use authorization application to the FDA for ‎COVI-STIX™ rapid test for the detection of SARS-CoV-2 Viral Antigen.‎

    ‎UP Fintech Holding Limited (TIGR), a Capital Markets company, dropped about -‎‎2.79% at $7.66 in pre-market trading Wednesday.‎

    ‎Energous Corporation (WATT) stock moved up 13.98 percent to $2.12 in the pre-‎market trading following the declaration from the company that current board director Dan Fairfax has ‎been named chairman of the board as current Chairman Robert J.‎

    ‎Acasti Pharma Inc. (ACST) stock soared 25.92% to $0.3148 in the pre-‎‎‎‎market ‎trading. ‎The most recent rating by Oppenheimer, on September 01, 2020, is a Perform.‎

    ‎Tonix Pharmaceuticals Holding Corp. (TNXP) gained over 5.15% at $0.6008 in pre-‎market trading Wednesday December 23, 2020 after revealing an agreement whereby Tonix has ‎acquired the exclusive license to the University of Geneva’s technology for using oxytocin to treat ‎insulin resistance and related syndromes, including obesity, from privately held Katana ‎Pharmaceuticals, Inc.‎

    ‎BP p.l.c. (BP) is up more than 2.34% at $20.96 in pre-market hours Wednesday ‎December 23, 2020. The stock had dropped over -0.97% to $20.48 in the last trading session.‎

    Before the trading started on December 23, 2020, Evofem Biosciences Inc. (EVFM) ‎is up 6.61% to reach $2.58 after reporting that it will participate in Medicaid National Drug rebate ‎program for Phexxi® Effective January 1, 2021. It has been trading in a 52-week range of $1.91 to $7.21.‎

    ‎Cloudera Inc. (CLDR) is up more than 5.6% at $15.46 in pre-‎‎‎‎‎market ‎hours ‎Wednesday December 23, 2020. The stock had jumped over 13.31% ‎to ‎‎$14.64 ‎in ‎the ‎last ‎trading ‎session.‎

    ‎Advaxis Inc. (ADXS) stock soared 39.07% to $0.4357 in the pre-market trading ‎following the announcement of listing transfer to Nasdaq Capital Market and additional 180-day ‎eExtension by Nasdaq to regain compliance with minimum bid price rule.‎ The most recent rating by ‎Barclays, on August 03, 2016, is an Overweight. ‎

    ‎Nikola Corporation (NASDAQ: NKLA) shares are trading down -2.97% at $16.33 at ‎the time of writing after reporting that Nikola and Republic Services (NYSE: RSG) have discontinued ‎their collaboration on refuse truck development. Company’s 52-week ranged between $10.30 to ‎‎$93.99. Analysts have a consensus price target of $20.‎

    Before the trading started on December 23, ‎‎2020, ‎‎Oragenics ‎Inc. ‎‎(OGEN) ‎is ‎up ‎‎8.3% ‎to reach $0.4841. It has been trading in a 52-‎week ‎range of $0.36 to ‎‎$2.09.‎

    ‎Bionano Genomics Inc. (BNGO) grew over 1.45% at $0.56 in pre-market trading ‎today after reporting publication revealing in side-by-side comparison that method using PacBio ‎sequencing detects only 72% of the large structural variants detected by Optical Genome Mapping ‎with Saphyr.‎

    ‎Palatin Technologies Inc. (PTN) gained over 7.96% at $0.61 in pre-‎‎‎‎‎‎‎market ‎trading ‎Wednesday December 23, 2020.‎

  • Early Morning Vibes: 4 Solid Stocks for Wednesday Trading Session

    Early Morning Vibes: 4 Solid Stocks for Wednesday Trading Session

    Good Morning

    On December 22, the American stock indexes finished trading in different directions. The S&P 500 dropped by 0.21% to 3687 points, the Dow Jones fell at a rate of 0.67%, while the NASDAQ climbed at 0.51%. Consumer confidence was significantly worse than expected. The tech sector became the leader of growth with a result of 0.86%; Apple shares acted as the engine, rising in price by 2.85%. The communications sector was one of the outsiders, losing 0.99%.
     

    Corporate Highlights

    Peloton Interactive (PTON: + 11.7%) buys exercise equipment manufacturer Precor for $ 420 million to increase production capacity.
     

    Revenue and EPS CarMax (KMX: -8.1%) were better than expected, but profit margins fell, and demand weakened at the end of the quarter due to COVID-19.

    Sports goods retailer Sportsman’s Warehouse Holdings (SPWH: + 39.6%) will be acquired by the Great American Outdoors Group.
     

    Today, world stock exchanges are showing mostly positive dynamics. The focus of attention is the unexpected statement by Donald Trump about his intention to change the parameters of the economic aid package, for which Congressmen voted yesterday. The current president believes that the one-time payment to the population should be increased from $ 600 per person to $ 2,000. Joseph Biden also noted that it is necessary to expand stimulus measures. Additional cash payments to the population should be included in the next package of assistance to the economy. Most likely, Trump will still sign the bill in the coming days.
     

    New strains of coronavirus continue to cause concern for investors, although virology experts believe that the vaccines available today are effective against the mutated COVID-19. Representatives of AstraZeneca and BioNTech agree.

    Nevertheless, full-fledged research has not yet been carried out. There is no complete confidence in this issue. In general, the news background is close to neutral, but the publication of the macrostatistics block may shift the balance in one direction or another.
     

    Economic Highlights
     

    Today there are weekly data on the number of initial applications for unemployment benefits. The indicator is expected to remain at the level of the previous week – 885

    thousand. If the actual value turns out to be above 893 thousand, it will become the highest since August. The labor market situation remains challenging. More than 5.5 million Americans are currently receiving unemployment benefits.

    Also, the indicator of the expenses of individuals for November will be published. Against the backdrop of new quarantine restrictions, consumption is expected to decrease.
     

    By 0.2% compared to October levels, which will be the first negative value since April. A month earlier, expenses increased by 0.5%.

    Today Top Movers‎

    ‎‎‎Hexo Corp (HEXO)‎‎ share price gaining 300.00% at $4.08 in early morning trading session today following its declaration of lapse of base shelf prospectus.‎‎ ‎

    ‎‎‎Ocugen, Inc (OCGN)‎‎ increasing 83.81% at $1.48 during premarket trading on Wednesday after the company and Bharat Biotech declared the signing of binding letter of intent (LOI) to co-develop Bharat Biotech’s COVID-19 vaccine candidate, COVAXIN, for the United States market.‎‎ ‎

    ‎‎‎Jaguar Health Inc (JAGX)‎‎ is up 52.85% at $0.61 in today’s premarket trading session after declaring the voting results of Jaguar’s December 9, 2020 in the Special Meeting of Stockholders.‎‎ ‎

    ‎‎‎Onconova Therapeutics Inc (ONTX)‎‎ share price changing with the gain of 38.76% at $0.59 in premarket trading on Wednesday after announcing FDA Permission for study to proceed under its investigational new drug application for Multi-kinase CDK4/6 Inhibitor ON 123300.

    Top Upgrades & Downgrades


    Truist Securities turned bullish on Pioneer Natural Resources Company (PXD), upgrading the stock to “Buy” and assigning a $135.0 price target.
     

    Rent-A-Center Inc. (RCII) has won the favor of Loop Capital’s equity research team. The firm upgraded the shares from Hold to Buy and moved their price target to $50.
     

    Illumina Inc. (ILMN) received an upgrade from analysts at Piper Sandler, who also set their one-year price target on the stock to $415.0. They changed their rating on ILMN to Overweight from Neutral in a recently issued research note.
     

    Earlier Wednesday BMO Capital reduced its rating on Fubotv Inc (NYSE: FUBO) stock to Market Perform from Outperform and assigned the price target to $50.
     

    Canaccord Genuity analysts reduced their investment ratings, saying in research reports covered by the media that its rating for Paysign Inc (NASDAQ: PAYS) has been changed to Hold from Buy and the new price target is set at $5.
     

    Analysts at BMO Capital downgraded IAC/Interactivecorp (NASDAQ: IAC)’s stock to Market Perform from Outperform on Wednesday.

    Latest Insider Activity


    FireEye Inc. (FEYE) EVP and General Counsel King Alexa announced the sale of shares taking place on Dec 21 at $20.03 for some 56,532 shares. The total came to more than $1.13 million.
     

    Apartment Investment and Management Company (AIV) Director STEIN MICHAEL A sold on Dec 21 a total 0 shares at $4.70 on average. The insider’s sale generated proceeds of almost $0.22 million.
     

    GameStop Corp. (GME) 10% Owner Cohen Ryan declared the purchase of shares taking place on Dec 18 at $15.97 for some 756,089 shares. The transaction amount was around $12.08 million.
     

    Upstart Holdings Inc. (UPST) 10% Owner Loeb Daniel S bought on Dec 18 a total 13,381,222 shares at $20.00 on average. The purchase cost the insider an estimated $24.0 million.

    Earnings To Watch


    Top US earnings releases scheduled for today include Paychex Inc. (NASDAQ:PAYX). It will announce its Nov 2020 financial results. The company is expected to report earnings of $0.66 per share from revenues of $954M in the three-month period.
     

    Analysts expect Bridgeline Digital Inc. (NASDAQ:BLIN) to report a net income (adjusted) of $0.03 per share, when the bank releases its quarterly results shortly. Revenue for the fiscal quarter ended Sep 2020 is predicted to come in at $2.64M.

  • Pre-Market Cues: 28 Stocks Roaring for Change On December 18th

    Pre-Market Cues: 28 Stocks Roaring for Change On December 18th

    Seneca Biopharma Inc. (SNCA), a Biotechnology company, rose about 0.2% at $0.96 in pre-market trading Friday after declaring merger agreement with Leading BioSciences, Inc. under which a wholly owned subsidiary of Seneca will merge with LBS in an all-stock transaction.

    Palantir Technologies Inc. (PLTR) lost over -3.97% at $26.15 in pre-market trading Friday December 18, 2020 after reporting that it will hold its inaugural “Live Demo Day” on Tuesday, January 26, 2021 at 4:30pm ET.

    Atossa Therapeutics Inc. (ATOS) stock plunged -0.02% to $0.86 in the pre-market trading following its declaration of pricing of $14.0 million registered direct offering priced at-the-market. The most recent rating by Maxim Group, on January 26, 2018, is a Buy.

    Virgin Galactic Holdings Inc. (NYSE: SPCE) shares are trading down -6.27% at $23.9 at the time of writing. The company recently revealed an update following its test flight on December 12, 2020. Company’s 52-week ranged between $9.06 to $42.49. Analysts have a consensus price target of $19.

    BlackBerry Limited (BB), a Software – Infrastructure company, dropped about -4.36% at $7.9 in pre-market trading Friday after releasing its financial results for the three months ended November 30, 2020

    Before the trading started on December 18, 2020, Uxin Limited (UXIN) is up 4.5% to reach $1.16 following its announcement of unaudited financial results for the quarter ended September 30, 2020. It has been trading in a 52-week range of $0.72 to $3.07.

    Coeur Mining Inc. (CDE) stock plunged -2.98% to $10.76 in the pre-market trading. The firm recently revealed details of the expansion of its Rochester silver-gold mine in Nevada, reflecting significant reserve growth and the benefits of a larger-scale expansion project. The most recent rating by Noble Capital Markets, on September 14, 2020, is an Outperform.

    Novan Inc. (NASDAQ: NOVN) shares are trading up 6.25% at $0.68 at the time of writing. The company lately reported that it has enrolled 525 patients of the approximately 850 patients expected to enroll in the B-SIMPLE4 pivotal Phase 3 clinical study of SB206. Company’s 52-week ranged between $0.22 to $3.72.

    CNS Pharmaceuticals Inc. (CNSP), a Biotechnology company, rose about 15.2% at $2.88 in pre-market trading Friday after announcing FDA approval of IND application for its brain cancer drug candidate Berubicin.

    United States Steel Corporation (X) stock moved down -4.26 percent to $17.77 in the pre-market trading after reporting that fourth quarter 2020 adjusted EBITDA is expected to be approximately $55 million and expected fourth quarter 2020 adjusted diluted loss per share to be approximately ($0.85).

    BioCardia Inc. (BCDA) lost over -6.09% at $4.01 in pre-market trading Friday December 18, 2020 following an announcement from the firm that the independent Data Safety Monitoring Board (DSMB) has completed its prespecified data review for the Phase III pivotal CardiAMP Heart Failure Trial.

    Before the trading started on December 18, 2020, Ampio Pharmaceuticals Inc. (AMPE) is up 8.43% to reach $1.93 after revealing the completion of its Phase I clinical trial and initiation of the first steps for a global Phase II clinical trial for intravenous (“IV”) Ampion treatment in COVID-19 patients. It has been trading in a 52-week range of $0.31 to $1.69.

    Drive Shack Inc. (NYSE: DS) shares are trading up 5.47% at $3.47 at the time of writing following the opening of its 65,000-square-foot entertainment golf venue located in Orlando. Company’s 52-week ranged between $0.86 to $4.19. Analysts have a consensus price target of $4.

    IZEA Worldwide Inc. (IZEA) tumbled over -3.7% at $1.04 in pre-market trading today. The company recently reported that it has just been awarded a mid-six figure contract from a Fortune 500 Manufacturer.

    Exela Technologies Inc. (XELA), a Software – Application company, rose about 81.87% at $0.66 in pre-market trading Friday after declaring that it has entered into a 5-year, $145 million term loan facility with Angelo Gordon, a global alternative investment firm.

    FedEx Corporation (FDX) stock moved down -2.89 percent to $283.8 in the pre-market trading after declaring strong results for the quarter ended November 30.

    Guardion Health Sciences Inc. (GHSI) stock plunged -2.13% to $0.23 in the pre-market trading. The firm recently declared progress on the introduction of its new vision support/energy drink, Epiq-V, which is under development for the United States and international markets.

    Amyris Inc. (NASDAQ: AMRS) shares are trading up 3.68% at $4.23 at the time of writing. Company’s 52-week ranged between $1.40 to $6.07. Analysts have a consensus price target of $3.35.

    Mereo BioPharma Group plc (MREO), a Biotechnology company, rose about 40.27% at $3.1 in pre-market trading Friday following the declaration of a license and collaboration agreement with Ultragenyx Pharmaceutical Inc. (RARE), for setrusumab, a monoclonal antibody in clinical development for osteogenesis imperfecta (OI).

    Surface Oncology Inc. (SURF) gained over 17.51% at $10.0 in pre-market trading Friday December 18, 2020 after revealing exclusive license agreement with GSK for novel immunotherapy program.

    Neovasc Inc. (NVCN) is down more than -8.52% at $0.91 in pre-market hours Friday December 18, 2020 after reporting the publication of peer-reviewed article in EuroIntervention. The stock had jumped over 3.61% to $0.99 in the last trading session.

    BioLineRx Ltd. (BLRX) tumbled over -1.1% at $2.7 in pre-market trading today. The firm lately declared final results from Phase 2a COMBAT/KEYNOTE-202 triple combination study of Motixafortide in second line Metastatic Pancreatic Cancer (PDAC).

    VYNE Therapeutics Inc. (VYNE), a Biotechnology company, rose about 8.05% at $1.88 in pre-market trading Friday after declaring the successful completion of its End-of-Phase 2 Meeting with the U.S. Food and Drug Administration (FDA).

    Before the trading started on December 18, 2020, Mesoblast Limited (MESO) is down -26.75% to reach $9.94 after announcing an update on COVID-19 ARDS trial. It has been trading in a 52-week range of $3.12 to $21.28.

    Applied DNA Sciences Inc. (APDN) stock plunged -12.02% to $5.49 in the pre-market trading after reporting consolidated financial results for the full fiscal year and quarter ended September 30, 2020. The most recent rating by H.C. Wainwright, on July 20, 2020, is a Buy.

    Conformis Inc. (NASDAQ: CFMS) shares are trading up 3.8% at $0.6693 at the time of writing. The firm lately revealed the U.S. commercial launch of the Company’s new Cordera™ Match Hip System. Company’s 52-week ranged between $0.50 to $1.66.

    Auris Medical Holding Ltd. (EARS) grew over 1.5% at $2.7 in pre-market trading today. The company recently provided a business update related to the Company’s funding position, its AM-301 program for the protection against airborne pathogens and allergens and the ongoing strategy review process.

    Sonoma Pharmaceuticals Inc. (SNOA) stock moved up 19.79 percent to $9.14 in the pre-market trading following the announcement of partnership with Gabriel Science, LLC for dental.

  • Top key players of Biotech Industry

    Top key players of Biotech Industry

    It is evident with so many people focused on COVID-19 that biotech stocks with coronavirus vaccines and treatments have gained a lot of attention.

    The Pfizer and BioNTech vaccine is developed on mRNA science, more straightforward, quicker, and cheaper to produce than standard vaccines. Even so, amid the enormous capital and expertise of Pfizer, the large pharmaceutical firm has failed to reach the production goals it initially set for the vaccine, needing to cut the original 100 million doses in 2020 to 50 million last month.

    The development issues are not restricted to vaccines for Covid-19 either. The FDA authorized the use of antibody drugs to treat Covid-19 last month, for example, complicated to develop. Other indications include diagnostics and cell therapies are in development. Flowing are the key performers from the Biotech sectors in yesterday’s market session.

    Xenetic Biosciences Inc. (NASDAQ:XBIO) shares were trading up 193.52% at $3.17 at the time of writing on Wednesday following declaration that it saw positive data from its partner PJSC Pharmsynthez about its pivotal Phase 3 clinical study leveraging PolyXen to develop a treatment for anemia in patients with chronic kidney disease (CKD).

    Xenetic Biosciences Inc. (NASDAQ:XBIO) share price went from a low point around $0.44 to briefly over $1.85 in past 52 weeks, though shares have since pulled back to $3.17. XBIO market cap has remained high, hitting $20.45M at the time of writing, giving it price-to-sales ratio of more than 60.

    If we look at the recent analyst rating XBIO, Maxim Group initiated coverage on XBIO shares with a Buy rating.

    Moderna Inc. (MRNA) last closed at $156.59, in a 52-week range of $17.68 to $178.50. The healthcare firm recently declared that the Swiss Federal Government has increased its confirmed order commitment from 4.5 million to 7.5 million doses of Moderna’s vaccine candidate against COVID-19, mRNA-1273. Analysts have a consensus price target of $122.60.

    GeoVax Labs Inc. (GOVX) stock soar by 79.06% to $5.73. The company on November 30, 2020 reported license agreement with NIH to support continued advancements in vaccine development. The most recent rating by Maxim Group, on November 19, 2020, is at a Buy.

    Intec Pharma Ltd (NASDAQ:NTEC) Shares headed rising, higher as much as 34.10% after declaring that it has entered into a feasibility agreement with GW Research Limited, London, U.K. to explore using the Accordion Pill (AP) platform for an undisclosed research program.. The most recent rating by Ladenburg Thalmann, on December 09, 2020, is at a Buy.

    Atossa Therapeutics Inc. (NASDAQ:ATOS) fall -39.03% after losing more than -$0.56 on Wednesday after the company reported pricing of $20.0 million underwritten public offering.

    Sorrento Therapeutics Inc. (SRNE) last closed at $8.21, in a 52-week range of $1.55 to $19.39. The company reported that it received US FDA clearance to proceed with Phase 1 Clinical Trials for STI-2020 (COVI-AMG) in healthy volunteers and in newly diagnosed COVID-19 Patients.

    Greenwich LifeSciences Inc. (GLSI) stock soar by 998.35% to $57.10 after reporting the publication of a poster for the GP2 Phase IIb clinical trial final efficacy analysis at the San Antonio Breast Cancer Symposium in a virtual format.

    Jaguar Health Inc. (NASDAQ:JAGX) Shares headed falling, lower as much as -11.45%. The most recent rating by Rodman & Renshaw, on July 11, 2017, is at a Buy.

    Lipocine Inc. (NASDAQ:LPCN) fall -21.43% after losing more than -$0.36 on Wednesday following the announcement from the company that the U.S. Food and Drug Administration has granted tentative approval to TLANDO

    Tonix Pharmaceuticals Holding Corp. (TNXP) last closed at $0.64, in a 52-week range of $0.39 to $2.46. On December 3, 2020, the firm declared positive phase 3 RELIEF study results for TNX-102 SL 5.6 mg in Fibromyalgia.

    SELLAS Life Sciences Group Inc. (SLS) stock soar by 73.17% to $6.39. The company on December 7, 2020 revealed an exclusive license agreement with 3D Medicines for development and commercialization of Galinpepimut-S (GPS) and GPS+ in Greater China. The most recent rating by Oppenheimer, on November 01, 2018, is at an Outperform.

    AIkido Pharma Inc. (NASDAQ:AIKI) Shares headed rising, higher as much as 4.07% after declaring the publication of positive results from its Artificial Intelligence/Machine Learning Sponsored Research Program in the field of Pancreatic Cancer.

    Celsion Corporation (NASDAQ:CLSN) rose 12.90% after gaining more than $0.08 on Wednesday.

    ADMA Biologics Inc. (ADMA) last closed at $2.22, in a 52-week range of $1.45 to $4.65. The firm recently announced $100 million credit facility loan amendment with perceptive advisors.

    Onconova Therapeutics Inc. (ONTX) stock soar by 1.75% to $0.32. On November 23, 2020, the company reported the filing of an investigational new drug application for Multi-kinase CDK4/6 Inhibitor ON 123300. The most recent rating by H.C. Wainwright, on March 01, 2018, is at a Buy.

  • What changed for these 30 stocks in Pre Market Session

    What changed for these 30 stocks in Pre Market Session

    Usio Inc. (USIO) stock soared 41.54% to $2.59 in the pre-market trading after declaring that it has entered into a non-binding Letter of Intent (LOI) to acquire the assets of Information Management Solutions, LLC (IMS).
    NeuroMetrix Inc. (NURO), a Medical Instruments & Supplies company, dropped about -8.03% at $2.75 in pre-market trading Wednesday.
    Cinedigm Corp. (CIDM) stock moved up 43.36 percent to $1.23 in the pre-market trading following a strategic alliance with Spherex to drive Cinedigm’s global growth.
    Recon Technology Ltd. (RCON) stock moved up 112.5 percent to $3.06 in the pre-market trading.
    Curis Inc. (NASDAQ: CRIS) shares are trading up 2.29% at $6.7 at the time of writing after revealing proposed public offering of common Stock. Company’s 52-week ranged between $0.62 to $3.59. Analysts have a consensus price target of $5.
    Gran Tierra Energy Inc. (GTE) lost over -7.04% at $0.355 in pre-market trading Wednesday December 09, 2020. The firm recently declared a financial update and the Company’s 2021 capital budget and production guidance.
    Aurora Cannabis Inc. (ACB) is down more than -0.94% at $10.5 in pre-market hours Wednesday December 09, 2020. The stock had jumped over 1.24% to $10.60 in the last trading session.
    Carnival Corporation & Plc (CCL) is up more than 2.76% at $24.22 in pre-market hours Wednesday December 09, 2020 following declaration of Cunard, a part of Carnival Corporation & plc (CCL), that it has extended its pause in operations due to the ongoing travel constraints in place across the world. The stock had jumped over 1.59% to $23.57 in the last trading session.
    Before the trading started on December 09, 2020, Occidental Petroleum Corporation (OXY) is up 2.56% to reach $19.62 after reporting upsize of previously announced cash tender offers and consent solicitations for certain of its senior notes. It has been trading in a 52-week range of $8.52 to $47.58.
    Virgin Galactic Holdings Inc. (SPCE) stock soared 2.55% to $34.24 in the pre-market trading. The most recent rating by Goldman, on October 23, 2020, is a Neutral.
    Eastman Kodak Company (NYSE: KODK) shares are trading down -4.04% at $10.7 at the time of writing after getting clean chit from U.S government regarding a government loan. Company’s 52-week ranged between $1.50 to $60.00.
    Moderna Inc. (MRNA) grew over 3.38% at $175.6 in pre-market trading today after declaring that the Swiss Federal Government has increased its confirmed order commitment from 4.5 million to 7.5 million doses of Moderna’s vaccine candidate against COVID-19, mRNA-1273.
    Riot Blockchain Inc. (RIOT), a Software – Application company, dropped about -5.78% at $9.3 in pre-market trading Wednesday.
    Norwegian Cruise Line Holdings Ltd. (NCLH), a Travel Services company, rose about 1.95% at $28.7 in pre-market trading Wednesday after announcing partnership with AtmosAir Solutions.
    XPeng Inc. (XPEV) stock moved down -3.72 percent to $46.88 in the pre-market trading following the pricing of follow-on public offering of American depositary shares.
    Cinemark Holdings Inc. (CNK) stock soared 2.26% to $15.36 in the pre-market trading. The most recent rating by Loop Capital, on November 19, 2020, is a Hold.
    Before the trading started on December 09, 2020, Tonix Pharmaceuticals Holding Corp. (TNXP) is up 0.15% to reach $0.65 after declaring results of positive phase 3 RELIEF study for TNX-102 SL 5.6 mg in Fibromyalgia. It has been trading in a 52-week range of $0.39 to $2.46.
    CBAK Energy Technology Inc. (NASDAQ: CBAT) shares are trading up 3.3% at $5.95 at the time of writing following the publication of securities purchase agreement with certain institutional investors for a registered direct placement of approximately $49.2 million of common stock at a price of $5.18 per share. Company’s 52-week ranged between $0.36 to $11.40.
    Jaguar Health Inc. (NASDAQ: JAGX) shares are trading down -4.84% at $0.3798 at the time of writing. Company’s 52-week ranged between $0.19 to $1.08. Analysts have a consensus price target of $2.
    United Airlines Holdings Inc. (UAL) grew over 1.88% at $49.96 in pre-market trading today after launching virtual, on demand customer service at the airport.
    GameStop Corp. (GME) is down more than -17.59% at $13.96 in pre-market hours Wednesday December 09, 2020 after releasing results for the third quarter ended October 31, 2020. The stock had jumped over 3.61% to $16.94 in the last trading session.
    Before the trading started on December 09, 2020, ADMA Biologics Inc. (ADMA) is up 4.31% to reach $2.18. It has been trading in a 52-week range of $1.45 to $4.65.
    Before the trading started on December 09, 2020, HEXO Corp. (HEXO) is down -2.91% to reach $1.0. The firm recently reported downward revision to its proposed share consolidation ratio. It has been trading in a 52-week range of $0.35 to $2.30.
    United Microelectronics Corporation (UMC) is up more than 1.37% at $8.88 in pre-market hours Wednesday December 09, 2020 afterreporting unaudited net sales for the month of November 2020. The stock had dropped over -3.10% to $8.76 in the last trading session.
    Apache Corporation (NASDAQ: APA) shares are trading up 1.08% at $14.92 at the time of writing following the board of directors of Apache Corporation (APA) has declared a regular cash dividend on the company’s common shares. Company’s 52-week ranged between $3.80 to $33.77. Analysts have a consensus price target of $16.
    Phunware Inc. (PHUN) stock moved down -3.28 percent to $0.81 in the pre-market trading after revealing its receipt of the Privacy Shield certification.
    Sorrento Therapeutics Inc. (SRNE) stock soared 9.62% to $8.66 in the pre-market trading after declaring that it has received CLIA Licensure from the State of California that permits testing of clinical samples. The most recent rating by H.C. Wainwright, on July 31, 2020, is a Buy.
    Sesen Bio Inc. (SESN) gained over 5.42% at $1.75 in pre-market trading Wednesday December 09, 2020 following the announcement of commercial manufacturing and global supply partnership with Qilu Pharmaceutical.
    Before the trading started on December 09, 2020, Futu Holdings Limited (FUTU) is up 2.27% to reach $44.61 after reporting that a leading global investment firm has agreed to purchase approximately 50,000,000 Class A ordinary shares of the Company in the form of prepaid warrants for an aggregate purchase price of approximately US$260,000,000. It has been trading in a 52-week range of $8.16 to $51.10.
    Westwater Resources Inc. (WWR) stock soared 3.87% to $5.63 in the pre-market trading. The company recently provided an update on progress at its pilot plant operations at Dorfner Anzaplan’s facilities near Amberg, Germany, as well as at facilities in Frankfort, Germany, Chicago, Illinois, and Buffalo, New York.

  • Onconova Therapeutics, Inc. (NASDAQ: ONTX), stock rising above the skies in the pre-market

    Onconova Therapeutics, Inc. (NASDAQ: ONTX), stock rising above the skies in the pre-market

    Onconova Therapeutics, Inc. (NASDAQ: ONTX), a biotechnology corporation dedicated to the research and production of innovative cancer therapy drugs surged over 31% at $0.38 in pre-market trading Tuesday, on no news.

    However, recently the company announced the registration with the U.S. of an Investigational New Drug (IND) application Food and Drug Administration (FDA) for the patented, differentiated, first-in-class multi-kinase inhibitor of the Business, ON 123300. The IND is seeking permission to launch a Phase 1 trial with ON 123300 in patients with HR+ HER 2-metastatic breast cancer with resistance to licenced second-generation CDK4/6 inhibitors for relapsed/refractory advanced cancer.

  • 18 Biotech Stocks That Are Great Options To Invest In

    18 Biotech Stocks That Are Great Options To Invest In

    The biotech industry is considered to be an attractive industry for the investor. This industry is continuously adopting new technological advancements. As time passes by every aspect of daily existence experience changes because of new technological breakthroughs and advancement in knowledge. Technology plays an important role in changing the lifestyle of humans. This technology also plays a very important role in the biotech industry.

    This technology has historically grown quickly. The biotech industry is striving to develop a treatment for complex diseases. It is anticipated that in 2021, one of the continuing trends in biotech is the continued improvement and development of drug research. The new technology help researchers to improve and assess diagnosis and treatment using medications.

    Check out the top 18 biotech companies you should add to your portfolio:

    BioLineRx Ltd. (NASDAQ: BLRX)

    BioLineRx Ltd. (NASDAQ: BLRX) shares were trading up 33.78% at $1.98 at the time of writing on Friday. BioLineRx Ltd. (NASDAQ: BLRX) share price went from a low point around $1.06 to briefly over $3.04 in the past 52 weeks, though shares have since pulled back to $1.98. BLRX market cap has remained high, hitting $39.57M at the time of writing. BioLineRx Ltd. (BLRX) has earlier announced the promising results from the ongoing GENESIS Phase III trial motixafortide for stem cell mobilization (SCM) in multiple myeloma patients.

    Miragen Therapeutics Inc. (NASDAQ: MGEN)

    Miragen Therapeutics Inc. (NASDAQ: MGEN) last closed at $1.31, in a 52-week range of $0.31 to $2.27. Miragen Therapeutics Inc. (MGEN) has earlier acquired  Viridian Therapeutics, Inc. It has traded up 321.22% and traded down -42.29% from its 52-weeks high. Looking at its liquidity, it has a current ratio of 4.80 and a quick ratio of 4.80. This company has a market capitalization of $79.29 million at the time of writing.

    Equillium Inc. (NASDAQ: EQ)

    Equillium Inc. (NASDAQ: EQ) stock soar by 5.83% to $6.35. The most recent rating by H.C. Wainwright, on July 14, 2020, is at a Buy. Previously, Equillium Inc. (EQ) has revealed that it has received a ‘Study May Proceed letter’ from the U.S. Food and Drug Administration (FDA) to commence a Phase 3 clinical trial, titled  EQUINOX, evaluating itolizumab in hospitalized COVID-19 patients suffering from acute respiratory distress syndrome (ARDS).

    Titan Pharmaceuticals Inc. (NASDAQ: TTNP)

    Titan Pharmaceuticals Inc. (NASDAQ: TTNP) shares headed falling, lower as much as -3.24%. The most recent rating by Maxim Group, on June 26, 2019, is at a Buy. Titan Pharmaceuticals Inc. (TTNP) revealed the pricing of an underwritten public offering of 80,000,000 units at a price of $0.10 per unit. Each unit issued in the offering comprised of one share of common stock and one warrant to purchase one share of common stock.

    Trevena Inc. (NASDAQ: TRVN)

    Trevena Inc. (NASDAQ: TRVN) rose 2.34% after gaining more than $0.06 on Friday. Trevena Inc. (TRVN) has disclosed that oliceridine has been classified as a Schedule II controlled substance by the U.S. Drug Enforcement Administration (DEA). Looking at its liquidity, it has a current ratio of 16.20 and a quick ratio of 16.20. This company has a market capitalization of $381.29 million at the time of writing.

    Sorrento Therapeutics Inc. (NASDAQ: SRNE)

    Sorrento Therapeutics Inc. (NASDAQ: SRNE) last closed at $6.94, in a 52-week range of $1.45 to $19.39. Sorrento Therapeutics Inc. (SRNE) has earlier announced preclinical data about intravenous COVI-AMG™ (STI-2020; Affinity Matured COVI-GUARD) neutralizing antibody (nAb) in a preprint publication.

    iBio Inc. (AMEX: IBIO)

    iBio Inc. (AMEX: IBIO) shares headed falling, lower as much as -1.69%. The most recent rating by Alliance Global Partners, on June 26, 2020, is at a Buy. iBio Inc. (IBIO) has earlier appointed Dr. Alexandra Kropotova to its Board of Directors, effective as of October 14, 2020. Dr. Kropotova has also been chosen as a member of iBio’s new Science & Technology Committee, which shall be chaired by Dr. Philip Russell.

    Inovio Pharmaceuticals Inc. (NASDAQ: INO)

    Inovio Pharmaceuticals Inc. (NASDAQ: INO) fall -6.10% after losing more than -$0.64 on Friday. Inovio Pharmaceuticals Inc. (INO) announced that it is scheduled to release its third-quarter financial results of 2020 on November 9, 2020.  This company has a market capitalization of $1.76 billion at the time of writing.

    Vaxart Inc. (NASDAQ: VXRT)

    Vaxart Inc. (NASDAQ: VXRT) last closed at $4.92, in a 52-week range of $0.27 to $17.49. A class action has started on behalf of certain shareholders in Vaxart, Inc. It has traded up 1749.62% and traded down -71.87% from its 52-weeks high. Looking at its liquidity, it has a current ratio of 4.00 and a quick ratio of 4.00. This company has a market capitalization of $580.22 million at the time of writing.

    Axovant Gene Therapies Ltd. (NASDAQ: AXGT)

    Axovant Gene Therapies Ltd. (NASDAQ: AXGT) stock drop by -41.64% to $2.13. The most recent rating by Cantor Fitzgerald, on April 17, 2020, is at an Overweight. Axovant Gene Therapies Ltd. (AXGT) has earlier announced program updates on Friday, October 30, 2020, at 11:30 AM Eastern time, for the Company’s AXO-Lenti-PD gene therapy for Parkinson’s disease.

    Akebia Therapeutics Inc. (NASDAQ: AKBA)

    Akebia Therapeutics Inc. (NASDAQ: AKBA) shares headed falling, lower as much as -2.20%. The most recent rating by Needham, on November 14, 2019, is at a Buy. Akebia Therapeutics Inc. (AKBA) earlier revealed that it is scheduled to announce its financial results for the third quarter ended September 30, 2020, on November 5, 2020, before the opening of the market.

    Moderna Inc. (NASDAQ: MRNA)

    Moderna Inc. (NASDAQ: MRNA) fall -5.35% after losing more than -$3.81 on Friday. Moderna Inc. (MRNA) earlier revealed that it has been recognized as one of the global biopharmaceutical industry’s top employers in Science and ScienceCareers’ 2020 Top Employers Survey for the sixth consecutive year.

    Heat Biologics Inc. (NASDAQ: HTBX)

    Heat Biologics Inc. (NASDAQ: HTBX) stock soar by 3.45% to $1.20. The most recent rating by B. Riley Securities, on October 14, 2020, is at a Buy. Heat Biologics Inc. (HTBX) share price went from a low point around $0.19 to briefly over $4.30 in the past 52 weeks, though shares have since pulled back to $1.20. HTBX market cap has remained high, hitting $172.30 Million at the time of writing.

    Onconova Therapeutics Inc. (NASDAQ: ONTX)

    Onconova Therapeutics Inc. (NASDAQ: ONTX) last closed at $0.26, in a 52-week range of $0.10 to $1.56. Onconova Therapeutics Inc. (ONTX) revealed that Dr. Steven M. Fruchtman, President and Chief Executive Officer, will present a company update during the 2020 BIO Investor Forum Digital event taking place October 13-15.

    Clovis Oncology Inc. (NASDAQ: CLVS)

    Clovis Oncology Inc. (NASDAQ: CLVS) stock drop by -4.27% to $4.93. The most recent rating by H.C. Wainwright, on May 18, 2020, is at a Buy. Clovis Oncology Inc. (CLVS) is scheduled to release its third-quarter 2020 financial results on Thursday, November 5, 2020, before the open of the U.S. financial markets. Clovis’ senior management will host a conference call and live audio webcast at 8:30 a.m.

    BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX)

    BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX) shares headed rising, higher as much as 2.41%. The most recent rating by JP Morgan, on September 29, 2020, is at an Overweight. BioCryst Pharmaceuticals Inc. (BCRX) revealed that the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has granted oral, once-daily berotralstat a positive scientific opinion through the Early Access to Medicines Scheme (EAMS).

    Soligenix Inc. (NASDAQ: SNGX)

    Soligenix Inc. (NASDAQ: SNGX) rose 0.59% after gaining more than $0.01 on Friday. Soligenix Inc. (SNGX) has disclosed that continued optional treatment with SGX301 across all lesions during the compassionate use, safety portion of the trial (Cycle 3), for a total of 6 months in the study, continued to significantly improve responses and remained safe and well-tolerated in its FLASH study.

    Scholar Rock Holding Corporation (SRRK)

    Scholar Rock Holding Corporation (SRRK) last closed at $38.90, in a 52-week range of $6.95 to $46.50. Analysts have a consensus price target of $30.00. Scholar Rock Holding Corporation (SRRK) announced the pricing of an underwritten public offering of 2,948,718 shares of its common stock at a public offering price of $39.00 per share.

  • Here’s Why You Should Hold These 15 Biotech Stocks

    Here’s Why You Should Hold These 15 Biotech Stocks

    The biotechnology industry is considered to be an attractive industry for investors as the investors are always looking for safe and secure investments. This industry is a good option for investors as it is a strong and profitable industry. Companies in the biotechnology industry are continuously striving and exploring treatment for rare diseases. This industry has a significant contribution to the well-being of society. The biotechnology industry is constantly experiencing tech improvements and new scientific discoveries.

    Technology has always been at the heart of the biotechnology industry. New technological advancements are helpful for the biotechnology industry. This industry is anticipated to show a higher growth rate over the period of the next seven years. Globally, it is predicted that this industry will generate massive revenue in the coming years and it will also provide investment opportunities to investors who want to invest in the research and development of this industry.

    The following are the leading companies in the biotechnology industry. Let check how these companies are providing the best services to their clients:

    Sorrento Therapeutics Inc. (NASDAQ: SRNE)

    Sorrento Therapeutics Inc. (NASDAQ: SRNE) shares were trading down -10.49% at $9.30 at the time of writing on Friday. Sorrento Therapeutics Inc. (NASDAQ: SRNE) share price went from a low point around $1.45 to briefly over $19.39 in the past 52 weeks, though shares have since pulled back to $9.30. SRNE market cap has remained high, hitting $2.72B at the time of writing, giving it a price-to-sales ratio of more than 70.

    Sorrento Therapeutics Inc. (SRNE) has announced earlier that it has secured the receipt of clearance from a Brazilian regulatory agency to continue with a Phase 2 clinical trial of Abivertinib in mild, moderate, and severe COVID-19 patients. If we look at the recent analyst rating SRNE, H.C. Wainwright reiterated coverage on SRNE shares with a Buy rating.

    EyePoint Pharmaceuticals Inc. (NASDAQ: EYPT)

    EyePoint Pharmaceuticals Inc. (EYPT) last closed at $0.48, in a 52-week range of $0.46 to $2.69. EyePoint Pharmaceuticals Inc. (EYPT) revealed changes to its existing debt facility with CRG Servicing LLC (CRG). Under the terms of the amendment, CRG has waived the covenant associated with the Company’s net product revenue of DEXYCU and YUTIQ for the twelve-month period ending on December 31, 2020.

    Vaxart Inc. (NASDAQ: VXRT)

    Vaxart Inc. (VXRT) stock drop by -3.49% to $6.08. The most recent rating by H.C. Wainwright, on August 12, 2020, is at a Buy. The Schall Law Firm disclosed that the class-action lawsuit has been lodged against Vaxart, Inc. (VXRT)  for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

    Novan Inc. (NASDAQ: NOVN)

    Novan Inc. (NASDAQ: NOVN) shares headed falling, lower as much as -4.59%. The most recent rating by Piper Jaffray, on January 06, 2020, is at a Neutral. Novan Inc. (NOVN) revealed earlier that the positive in vitro results exhibited the potential efficacy of its NITRICIL™ platform technology as an antiviral against SARS-CoV-2, the virus that causes COVID-19.

    Akebia Therapeutics Inc. (NASDAQ: AKBA)

    Akebia Therapeutics Inc. (NASDAQ: AKBA) rose 3.42% after gaining more than $0.13 on Friday. Akebia Therapeutics Inc. (AKBA) revealed that it is scheduled to present data from its global Phase 3 programs of vadadustat for the treatment of anemia due to chronic kidney disease (CKD) in adult patients on dialysis ) and not on dialysis at the American Society of Nephrology Kidney Week 2020 Reimagined (ASN Kidney Week) on October 22 – 25, 2020.

    Royalty Pharma plc (NASDAQ: RPRX)

    Royalty Pharma plc (RPRX) last closed at $41.81, in a 52-week range of $38.54 to $56.50. Analysts have a consensus price target of $52.67. Royalty Pharma plc (RPRX) disclosed today that it is scheduled to announce its third-quarter 2020 financial results on Wednesday, November 11, 2020, before the U.S. financial markets open.

    Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX)

    Vertex Pharmaceuticals Incorporated (VRTX) stock soar by 1.30% to $218.08. The most recent rating by H.C. Wainwright, on July 31, 2020, is at a Buy. Vertex Pharmaceuticals Incorporated (VRTX) shared an update on its clinical programs targeting the small molecule correction of alpha-1 antitrypsin deficiency (AATD).

    iBio Inc. (AMEX: IBIO)

    iBio Inc. (AMEX: IBIO) Shares headed falling, lower as much as -1.44%. The most recent rating by Alliance Global Partners, on June 26, 2020, is at a Buy. iBio Inc. (IBIO) earlier revealed it has appointed Dr. Alexandra Kropotova to its Board of Directors, effective as of October 14, 2020. Dr. Kropotova has also been chosen as a member of iBio’s new Science & Technology Committee, which shall be chaired by Dr. Philip Russell.

    Onconova Therapeutics Inc. (NASDAQ: ONTX)

    Onconova Therapeutics Inc. (NASDAQ: ONTX) last closed at $0.29, in a 52-week range of $0.10 to $1.56. Onconova Therapeutics Inc. (ONTX) earlier disclosed that Dr. Steven M. Fruchtman, President and Chief Executive Officer, will present a company update during the 2020 BIO Investor Forum Digital event taking place October 13-15. Dr. Fruchtman and Avi Oler, Senior VP, Corporate Development, will be available for 1×1 meetings scheduled through the Bio Partnering system.

    Moderna Inc. (NASDAQ: MRNA)

    Moderna Inc. (NASDAQ: MRNA) Shares headed falling, lower as much as -2.17%. The most recent rating by SVB Leerink, on September 08, 2020, is at an Underperform. Moderna Inc. (MRNA) has earlier disclosed the initiation of a rolling submission to Health Canada for mRNA-1273. This initiation follows positive results from a preclinical viral challenge study of mRNA-1273 and the positive interim analysis of the Phase 1 study of mRNA-1273 in healthy adults and older adults.

    Selecta Biosciences Inc. (NASDAQ: SELB)

    Selecta Biosciences Inc. (NASDAQ: SELB) rose 18.01% after gaining more than $0.38 on Friday. Selecta Biosciences Inc. (SELB) has earlier announced an agreement with IGAN Biosciences, Inc. The agreement is the Research License and Option agreement signed to study Selecta’s ImmTOR™ immune tolerance platform in combination with IGAN’s immunoglobulin A (IgA) protease for the treatment of IgA Nephropathy (IgAN).

    Immunomedics Inc. (NASDAQ: IMMU)

    Immunomedics Inc. (NASDAQ: IMMU) stock soar by 0.08% to $87.56. The most recent rating by Barclays, on May 05, 2020, is at an Overweight. Immunomedics Inc. (IMMU) disclosed that the Office of Orphan Products Development of the U.S. Food and Drug Administration (FDA) has granted Trodelvy orphan status for the treatment of adult and pediatric patients with glioblastoma.

    Clovis Oncology Inc. (NASDAQ: CLVS)

    Clovis Oncology Inc. (NASDAQ: CLVS) fall -0.75% after losing more than -$0.05 on Friday. Clovis Oncology Inc. (CLVS) share price went from a low point around $2.93 to briefly over $17.37 in the past 52 weeks. It has moved up 102.56% from its 52-weeks low and moved down -65.83% from its 52-weeks high. CLVS market cap has remained high, hitting $532.72 million at the time of writing.

    Inovio Pharmaceuticals Inc. (NASDAQ: INO)

    Inovio Pharmaceuticals Inc. (NASDAQ: INO) stock drop by -2.95% to $11.85. The most recent rating by Maxim Group, on September 28, 2020, is at a Buy. Inovio Pharmaceuticals Inc. (INO) share price went from a low point around $2.09 to briefly over $33.79 in the past 52 weeks. It has moved up 456.84% from its 52-weeks low and moved down -65.56% from its 52-weeks high. INO market cap has remained high, hitting $2.05 Billion at the time of writing.

    MannKind Corporation (NASDAQ: MNKD)

    MannKind Corporation (NASDAQ: MNKD) last closed at $2.00, in a 52-week range of $0.80 to $2.48. MannKind Corporation (MNKD) has moved up 157.08% from its 52-weeks low and moved down -17.07% from its 52-weeks high. MNKD market cap has remained high, hitting $441.20 Million at the time of writing.

  • 20 Trending Stocks In Biotechnology Industry You Should Consider Buying

    20 Trending Stocks In Biotechnology Industry You Should Consider Buying

    Investors are always looking for safe and secure investments and as a strong and profitable industry, the biotechnology industry is considered to be an attractive area of investment. This industry has experienced massive growth in recent years and is continuously adopting new technological advancements to keep pace with the fast-growing market. Biotechnology is a set of tools that uses living organisms to create or change a product, improve plants, trees, or animals, or develop microorganisms for specific uses.

    Modern Biotechnology’s main focus is on medicine. The companies in this sector are involved in the development of new treatments for various complex diseases. Technology has always been at the heart of the biotechnology industry. As the new technologies emerged with the passage of time the efficiency of companies has also improved. Similarly, technological advancements have also changed the clinical trial process.

    There are various other trends that the companies are following. Let see the top 20 companies in the biotechnology industry to get a better view:

    Cassava Sciences Inc. (NASDAQ: SAVA)

    Cassava Sciences Inc. (NASDAQ: SAVA) last closed at $11.47, in a 52-week range of $1.05 to $11.25. Analysts have a consensus price target of $17.00. Cassava Sciences Inc. (SAVA) has earlier announced the results of the Phase 2b study with its drug candidate Sumifilam, in Alzheimer’s disease. The clinical study which has received the funding by the National Institutes of Health (NIH) has shown the improvement in Alzheimer’s disease. Cassava Sciences Inc. (SAVA) market cap has remained high, hitting $242.02 M at the time of writing.

    Inovio Pharmaceuticals Inc. (NASDAQ: INO)

    Inovio Pharmaceuticals Inc. (NASDAQ: INO) stock soar by 10.21% to $16.94. The most recent rating by ROTH Capital, on July 01, 2020, is at a Sell. Inovio Pharmaceuticals Inc. (INO) has revealed that the US Food and Drug Administration (FDA) has informed the company that it has some questions related to the Phase 2/3 trial of its COVID-19 vaccine candidate INO-4800, including its CELLECTRA 2000 delivery device to be used in the trial. the company said that it will halt the trial until it clear all the ambiguities of FDA.

    Sorrento Therapeutics Inc. (NASDAQ: SRNE)

    Sorrento Therapeutics Inc. (NASDAQ: SRNE) Shares headed rising, higher as much as 4.84%. The most recent rating by H.C. Wainwright, on July 31, 2020, is at a Buy. Sorrento Therapeutics Inc. (SRNE) has earlier revealed the results of its’ multicenter, open-label, Phase 1b Study to Evaluate Safety and MTD of Epidural Resiniferatoxin Injection for the Treatment of Intractable Cancer Pain at the 14th Annual Pain Therapeutics Summit. The company has reported the encouraging results from its Phase 1b study to evaluate Epidural Resiniferatoxin Injection.

    Vaxart Inc. (NASDAQ: VXRT)

    Vaxart Inc. (NASDAQ: VXRT) rose 7.40% after gaining more than $0.51 on Friday. Pomerantz LLP is investigating claims on behalf of investors of Vaxart, Inc. Vaxart Inc. share price went from a low point around $0.25 to briefly over $17.49 in the past 52 weeks, though shares have since pulled back to $7.40. Vaxart Inc.’s market cap has remained high, hitting $752.43 M at the time of writing.

    Novavax Inc. (NASDAQ: NVAX)

    Novavax Inc. (NASDAQ: NVAX) stock soar by 10.86% to $113.56. The most recent rating by H.C. Wainwright, on August 06, 2020, is at a Buy. Par Sterile Products, LLC (Par Sterile) has entered into a non-exclusive agreement with Novavax, Inc. to provide fill-finish manufacturing services at its plant in Rochester, Michigan for NVX-CoV2373, Novavax’ COVID-19 vaccine candidate.

    Onconova Therapeutics Inc. (NASDAQ: ONTX)

    Onconova Therapeutics Inc. (NASDAQ: ONTX) Shares headed falling, lower as much as -3.23%. The most recent rating by H.C. Wainwright, on March 01, 2018, is at a Buy. Onconova Therapeutics Inc. (ONTX) earlier revealed that it has started the Phase 1 clinical trial in China for ON 123300 by its partner, HanX Biopharmaceuticals. Onconova has partnered with HanX Biopharmaceuticals in December 2017 for the development, registration, and commercialization of ON 123300 in China.

    Jaguar Health Inc. (NASDAQ: JAGX)

    Jaguar Health Inc. (NASDAQ: JAGX) last closed at $0.31, in a 52-week range of $0.29 to $1.38. Jaguar Health Inc. (JAGX) earlier revealed itis scheduled to participate in its first “Diarrhea Dialogues” virtual event on October 20 from 3:00 PM. The event, open to the financial and business community, will discuss the importance of supportive care for cancer patients as it relates to chronic lower GI tract distress, specifically with regard to debilitating diarrhea experienced as a result of cancer therapy.

    Zogenix Inc. (NASDAQ: ZGNX)

    Zogenix Inc. (NASDAQ: ZGNX) stock drop by -1.46% to $17.50. The most recent rating by Raymond James, on August 25, 2020, is at an Mkt perform. Zogenix Inc. (ZGNX) has revealed the pricing of its offering of $200,000,000 aggregate principal amount of 2.75% convertible senior notes due 2027 in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended.

    Trevena Inc. (NASDAQ: TRVN)

    Trevena Inc. (NASDAQ: TRVN) Shares headed rising, higher as much as 4.04%. The most recent rating by Guggenheim, on September 14, 2020, is at a Buy. Trevena Inc. (TRVN) has earlier participated in three presentations at the virtual 2020 American College of Clinical Pharmacology (ACCP) Annual Meeting. The meetings have taken place from September 21st to 23rd, 2020.

    VBI Vaccines Inc. (NASDAQ: VBIV)

    VBI Vaccines Inc. (NASDAQ: VBIV) last closed at $3.08, in a 52-week range of $0.47 to $6.93. VBI Vaccines Inc. (VBIV) is scheduled to participate in upcoming presentations including Sci-B-Vac: Results on Ph3 Hep B vaccine, Targeting CMV for the development of effective GBM immunotherapy on September 29 and 30, 2020, respectively. It has today participated in the COVID-19 panel discussion on the topic: What existing treatments and vaccine development platforms show promise to control the rate of infection and spread?

    Brickell Biotech Inc. (NASDAQ: BBI)

    Brickell Biotech Inc. (NASDAQ: BBI) Shares headed rising, higher as much as 3.90%. The most recent rating by Lake Street, on August 28, 2020, is at a Buy. Brickell Biotech Inc. (BBI) has revealed that its Japanese development partner, Kaken Pharmaceutical Co., Ltd. has received approval to manufacture and market sofpironium bromide gel, 5% under the brand name ECCLOCK in Japan for the treatment of primary axillary (underarm) hyperhidrosis.

    VYNE Therapeutics Inc. (NASDAQ: VYNE)

    VYNE Therapeutics Inc. (NASDAQ: VYNE) Shares headed falling, lower as much as -6.17%. VYNE Therapeutics Inc. (VYNE) has revealed that the Company will host a physician symposium on AMZEEQ and ZILXI™ on Thursday, October 1, 2020. VYNE market cap has remained high, hitting $271.70-M at the time of writing.

    Acorda Therapeutics Inc. (NASDAQ: ACOR)

    Acorda Therapeutics Inc. (NASDAQ: ACOR) shares were trading up 30.13% at $0.62 at the time of writing on Friday. Acorda Therapeutics Inc. (NASDAQ: ACOR) share price went from a low point around $0.42 to briefly over $3.27 in the past 52 weeks, though shares have since pulled back to $0.62. ACOR market cap has remained high, hitting $22.70M at the time of writing, giving it a price-to-sales ratio of more than 0. If we look at the recent analyst rating ACOR, H.C. Wainwright downgraded coverage on ACOR shares with a Neutral rating.

    Moderna Inc. (NASDAQ: MRNA)

    Moderna Inc. (NASDAQ: MRNA) last closed at $69.47, in a 52-week range of $13.53 to $95.21. Analysts have a consensus price target of $91.90. Moderna Inc. (MRNA) has moved up 413.45% from its 52-weeks low and moved down -327.03% from its 52-weeks high. Looking at its liquidity, it has a current ratio of 17.30. This company’s market capitalization has remained high, hitting $25.72 billion at the time of writing.

    iBio Inc. (AMEX: IBIO)

    iBio Inc. (AMEX: IBIO) rose 7.77% after gaining more than $0.15 on Friday. iBio Inc. (IBIO) share price went from a low point around $0.05 to briefly over $7.45 in the past 52 weeks, though shares have since pulled back to $2.08. iBio Inc. has moved up 4060.00% from its 52-weeks low and moved down -72.08% from its 52-weeks high.  IBIO market cap has remained high, hitting $336.61 M at the time of writing.

    Akebia Therapeutics Inc. (NASDAQ: AKBA)

    Akebia Therapeutics Inc. (NASDAQ: AKBA) rose 0.81% after gaining more than $0.02 on Friday.  In the past 52-weeks of trading, this company’s stock has fluctuated between the low of $2.34 and a high of $13.71. It has moved up 5.98% from its 52-weeks low and moved down -8191% from its 52-weeks high. Looking at its liquidity, it has a current ratio of 2.30. This company’s market capitalization has remained high, hitting $347.50 million at the time of writing.

    Vaccinex Inc. (NASDAQ: VCNX)

    Vaccinex Inc. (NASDAQ: VCNX) stock drop by -1.10% to $1.79. The most recent rating by BTIG Research, on September 23, 2020, is at a Neutral. Vaccinex Inc. (VCNX) share price went from a low point around $1.70 to briefly over $12.23 in the past 52 weeks, though shares have since pulled back to $1.79. VCNX has moved up 5.29% from its 52-weeks low and moved down -85.36% from its 52-weeks high.  VCNX market cap has remained high, hitting $36.19M at the time of writing.

    Ocugen Inc. (NASDAQ: OCGN)

    Ocugen Inc. (NASDAQ: OCGN) rose 2.29% after gaining more than $0.0 on Friday. In the past 52-weeks of trading, this company’s stock has fluctuated between the low of $0.17 and a high of $16.80. It has moved up 78.53% from its 52-weeks low and moved down -98.19% from its 52-weeks high. Looking at its liquidity, it has a current ratio of 3.30. This company’s market capitalization has remained high, hitting $40.03 million at the time of writing.

    9 Meters Biopharma Inc. (NASDAQ: NMTR)

    9 Meters Biopharma Inc. (NMTR) last closed at $0.76, in a 52-week range of $0.37 to $1.22. 9 Meters Biopharma Inc. (NMTR) has moved up 106.59% from its 52-weeks low and moved down -37.33% from its 52-weeks high. Looking at its liquidity, it has a current ratio of 1.30. This company’s market capitalization has remained high, hitting $101.25 million at the time of writing.

    Clovis Oncology Inc. (NASDAQ: CLVS)

    Clovis Oncology Inc. (NASDAQ: CLVS) stock soar by 3.25% to $5.88. The most recent rating by H.C. Wainwright, on May 18, 2020, is at a Buy. Clovis Oncology Inc. (CLVS) share price went from a low point around $2.93 to briefly over $17.37 in the past 52 weeks, though shares have since pulled back to $5.88. CLVS has moved up 100.68% from its 52-weeks low and moved down -66.15% from its 52-weeks high.  CLVS market cap has remained high, hitting $502.33M at the time of writing.